ISSN: 1425-9524

Journal Home

Journal Guideline

Annals of Transplantation Q2 Unclaimed

International Scientific Information, Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Annals of Transplantation is a journal indexed in SJR in Medicine (miscellaneous) and Transplantation with an H index of 44. It has an SJR impact factor of 0,379 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,379.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Transplantation (Q2) Medicine (miscellaneous) (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,379

SJR Impact factor

44

H Index

43

Total Docs (Last Year)

214

Total Docs (3 years)

1208

Total Refs

257

Total Cites (3 years)

212

Citable Docs (3 years)

1.13

Cites/Doc (2 years)

28.09

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

The HELLP concept - Relatives of deceased donors need the Help Earlier in parallel with Loss of a Loved Person

Pharmacokinetic monitoring of mycophenolic acid in heart transplant patients: Correlation the side-effects and rejections with pharmacokinetic parameters

Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: A randomized, open-label multicenter study

Polypropylene mesh repair of incisional hernia after kidney transplantation: Single-center experience and review of the literature

Pre transplant serum magnesium level predicts outcome after pediatric living donor liver transplantation

Results of renal transplantation from expanded criteria deceased donors -a single-center experience

The significance of oral labial biopsy in hepatic graft-versus-host disease diagnosis in patients following allogeneic hematopoietic stem cell transplantation -a preliminary report

Differences in invasive fungal infections between liver and kidney transplant patients

Malignancy after kidney transplantation

Donor transmitted left atrial myxoma 13 years after heart transplantation

Intestinal ischemia-reperfusion injury -the histopathological status of remote vital organs in acute and subacute phases

Atorvastatin donor pre-treatment in a model of brain death and allogeneic kidney transplantation in rat

SHOW MORE ARTICLES

Hypertension in solid organ transplant recipients

Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantation

Nowotwory po przeszczepie nerki

Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients

Influence of conversion from cyclosporine A to tacrolimus on insulin sensitivity assessed by euglicaemic hyperinsulinemic clamp technique in patients after kidney transplantation

Ultrasonography of the brain, abdomen, and heart in neonates born to liver or renal transplant recipient mothers

Graft-versus-host disease after solid organ transplantation: A single center experience and review of literature

Selective use of extended criteria deceased liver donors with anatomic variations

Result of arm-level upper-limb transplantation in two recipients at 19- and 30-month follow-up

Contrast enhanced ultrasound cholangiography via T-tube following liver transplantation

Do thyroid disorders affect the postoperative course of patients in the early post-heart transplant period?

Immunosuppressive regimens containing generic mycophenolate mofetil (Myfenax) in de novo renal transplant recipients -preliminary results of 6-month observation